tykhr
sign in
free sign up
La Jolla Pharmaceutical Co
Biotechnology
Healthcare
LJPC
32.08 M shares
NASDAQ US
traded
19 Aug 2022
listed
yes
open
6.21
52 week high
6.22
high
6.23
52 week low
3.12
low
6.20
growth
42.33 %
previous Close
6.22
P/E ratio
market cap
155 M
div yield
0
usd
Jun 2022
qoq
revenue
10.54 M
1.13 %
net incoming
2.46 M
122.00 %
eps
0.00 %
153.33 %
eps surprise
300.00 %
net profit margin
23.31 %
23.00 %
operating incoming
-1.07 M
47.70 %
net change in cash
4.17 M
266.83 %
cash on hand
48.34 M
9.44 %
cost of revenue
1.69 M
-21.89 %
top